Jiangsu Hengrui Medicine Company Ltd.

Shanghai Hengrui Pharmaceutical Co., Ltd.

Huawei Technologies Co., Limited

Huawei Digital Power Technologies Co., Ltd.

Robert Boschgmbh

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Hao Zheng

Li Ping Wang

Xiao Yang

Li Wang

Christoph Woll

Peng Cho Tang

Nong Zhang

Hejun Lü

Hongbo Fei

Yiqian Chen

Zhou Zhu

Mengde Li

Weimin Wang

Shenglan Wang

Yinan Zhang

Linpeng Yin

Baolei Zhang

Lin Wu

Liangfei Lu

A distributed recording system includes a first device and one or more second devices. The first device sends a distributed recording instruction, to control the one or more second devices to perform recording. The one or more second devices send audio data obtained through recording to an upper-layer recording application.

Recording method and device

A six-phase flat wire wave winding structure. Each phase of wave winding structure has a wire-in end, a wire-out end, and a wire located between the wire-out end and the wire-in end. The six-phase flat wire wave winding structure is applicable to a 2M-layer (M=1, 2, 3 . . . ) six-phase motor whose quantity of slots of each phase in each pole is q, whose quantity of stator slots is 6q (q=1, 2, 3 . . . ) times of a quantity of poles, and whose quantity a of parallel branches is 1 or 2. Each phase of the wave winding structure has conductors in all layers of a same stator slot, and the wave windings are uniformly and symmetrically distributed. In addition, problems that a flat wire winding process is highly difficult and manufacturing costs are high due to an increase in a quantity of phases of the six-phase motor are effectively resolved.

Six-phase flat wire wave winding structure, six-phase motor, powertrain, and vehicle

Dihydroperidinone derivatives, preparation process and pharmaceutical use thereof are disclosed. Specially, new dihydroperidinone derivatives represented by general formula (I), wherein each substituent of the general formula (I) is defined as in the description, their preparation process, pharmaceutical compositions comprising said derivatives and their use as therapeutical agents, especially as Plk kinase inhibitors are disclosed. 

Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof

The bicyclo-substituted pyrazolon-azo derivatives of formula (I) or pharmaceutical acceptable salts, hydrates or solvates thereof, methods for their preparation, pharmaceutical compositions containing the same and their use as a therapeutic agent, especially as thrombopoietin (TPO) mimetics and their use as agonists of thrombopoietin receptor are disclosed. The definition of substituents in formula (I) are the same as defined in the description. 

Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof

Growing community of inventors

Shanghai, China

Hao Zheng